A more general explanation could be the hygiene hypothesis, referring to changing patterns of early childhood infections, which has also been suggested as a possible catalyst in the changing prevalence of CD4but is unlikely to explain the new occurrence of disease in the elderly. == Pathophysiology == Gluten is a mixture of proteins (including gliadins and glutenins) that are found in wheat grains. 0.03%.1This estimate was based on rates of clinically detected CD and for a long time it was felt that CD was rare in many Western populations with increased frequency in places such as the west of Ireland. Subsequently it became apparent that the rate of CD diagnosis was increasing and most assumed that it was due to greater detection due to use of serology linked to heightened suspicion.2The true prevalence is difficult to determine since there is a wide spectrum of symptoms associated with the disease.3The iceberg model of disease has been frequently applied to CD in that the tip of the iceberg represents patients with classic malabsorption, while the more atypical presentations represent the portion of the iceberg that is invisible, but much larger, below the waterline.4It is estimated that there may be eight times as many subclinical and silent celiac cases as there are classically symptomatic cases.5The ratio between diagnosed and undiagnosed cases may be even greater. In a population-based study, the seroprevalence of undiagnosed CD in patients aged 50 years or older was 0.8%.6 The real prevalence of CD, based largely on serological screening in the general populations of North America and Western Europe, is estimated to be between 0.5% and 1.26%, with a somewhat higher prevalence in the Scandinavian countries, Ireland, and the UK (where it was estimated to be between 1.0% and 1.5%).3 While most studies have been based on seroprevalence, one recent study confirmed high prevalence with parallel serology and histopathology in a population-based study. These patients had no symptoms or reasons to suspect that they had CD. When including patients with positive serology, increased intraepithelial lymphocytes (IELs) without atrophy, and two previously treated patients, the prevalence was 1.8%.7 This increase in prevalence is not solely due to more effective diagnostic methods. Recent studies from the USA and Europe have shown a 24.5-fold increase in the prevalence of CD.4,8,9One study showed a fourfold increase, comparing sera obtained from young men in the 1950s with present-day SB 525334 sera from cohorts of men with similar ages at testing and similar birth years.6This increase in prevalence in both age cohorts suggests the presence of pervasive environmental factor(s) that are triggering the development of CD in genetically susceptible individuals of any age. A more recent study showed increased prevalence in the same cohort of adults followed over 25 years.8There are many possible environmental factors that could be responsible, including changes in the timing of introduction, quality, quantity, or processing of cereal. In the last 40 years, there GNG12 have been many changes in wheat genetics, bread processing, and enzymatic modifications of wheat prolamins. A more general explanation could be the hygiene hypothesis, referring to changing patterns of early childhood infections, which has also been suggested as a possible catalyst in the changing prevalence of CD4but is unlikely to explain the new occurrence of disease in the elderly. == Pathophysiology == Gluten is a mixture of proteins (including gliadins and glutenins) that are found in wheat grains. Similar proteins from barley (hordeins) and rye (secalins) also induce injury.10Of these, the gliadin peptides are the most immunogenic for CD. These peptides resist complete digestion and likely pass across the intestinal epithelial barrier via both transcellular and paracellular mechanisms. Transcellular mechanisms include IFN- stimulated transcytosis via intracellular vesicles.11Paracellular mechanisms of peptide are thought to occur via increased intestinal permeability via so-called entry leaky tight junctions. One of the proteins involved in controlling tight junctions is zonulin. When gliadin binds to CXCR3 chemokine receptor, zonulin is released from intestinal cells. Ex vivo studies have shown that increased levels of zonulin lead to decreased transepithelial electrical resistance (TEER). In vivo studies in mice demonstrated that zonulin increased both gastric and small intestinal permeability. The mechanism by which zonulin achieves these changes in TEER and gut permeability is via activation of proteinase-activating receptor 2 (PAR2), which in turn activates epidermal growth factor receptor (EGFR). Activation of EGFR induces an EGFR-driven decrease in TEER. Expression of zonulin mRNA is increased in individuals with active CD, suggesting that this protein is SB 525334 related to intestinal damage in patients with CD.12 Gliadin peptides then stimulate intestinal CD4+ T cells in the lamina propria, although there is SB 525334 significant variability among epitopes of.